Imatinib Maintenance Following Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Philadelphia Chromosome Positive (PH+) Acute Lymphoblastic Leukemia (ALL)

Authors :: Nelson Hamerschlak
Farhad Ravandi
Paolo Anderlini
Richard E. Champlin
D. Jones
Partow Kebriaei
Laura L. Worth
Rima M. Saliba
Hagop M. Kantarjian
Sergio Giralt
Morgani Rodrigues
Alexandre Chiattone
M. de Lima
Daniel Thomas
Issa F. Khouri
Borje S. Andersson
Source :: Biology of Blood and Marrow Transplantation. 16(2)
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: Transplantation
Philadelphia Chromosome Positive
Hematopoietic cell
business.industry
Cancer research
Medicine
Imatinib
Hematology
business
female genital diseases and pregnancy complications
Ph+ acute lymphoblastic leukemia
medicine.drug

Full Text Access

Tools